Literature DB >> 17235495

How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?

Catherine Diamond1, Thomas H Taylor, Theresa Im, Mark Wallace, Alan Saven, Hoda Anton-Culver.   

Abstract

OBJECTIVE: We sought to determine the accuracy of cancer registry data regarding the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) status of patients with non-Hodgkin's lymphoma (NHL).
METHODS: We used the population-based San Diego/Orange County cancer registry to identify 392 patients with HIV-related NHL diagnosed 1994-1999. After matching for age, sex, race, period of NHL diagnosis, and hospital type, we were able to find 324 corresponding patients among the remaining 4,863 NHL patients diagnosed 1994-1999 (who did not have HIV infection according to cancer registry records). We sought to review these patients' charts at 41 hospitals with 15 separate institutional review boards to determine if the HIV serostatus from the cancer registry was correct. We performed a forward conditional multivariate logistic regression to determine characteristics associated with a false positive HIV status.
RESULTS: The false positive rate was 8% while the false negative rate was 3%. The positive predictive value was 93% while the negative predictive value was 97%. Compared to correctly identified patients, false positives were more likely to be > or =50 years old, female, and treated with chemotherapy and less likely to be single with high grade or extranodal disease.
CONCLUSION: Using cancer registry data to identify AIDS-related NHL is a valid research practice.

Entities:  

Mesh:

Year:  2007        PMID: 17235495     DOI: 10.1007/s10552-006-0096-5

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  Racial differences in primary central nervous system lymphoma incidence and survival rates.

Authors:  Jose S Pulido; Robert A Vierkant; Janet E Olson; Lauren Abrey; David Schiff; Brian Patrick O'Neill
Journal:  Neuro Oncol       Date:  2009-03-09       Impact factor: 12.300

2.  Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors.

Authors:  Elisabet E Manasanch; Jillian K Smith; Andreea Bodnari; Jeannine McKinney; Catherine Gray; Theodore P McDade; Jennifer F Tseng
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

3.  Survival among patients with primary central nervous system lymphoma, 1973-2004.

Authors:  Andrew D Norden; Jan Drappatz; Patrick Y Wen; Elizabeth B Claus
Journal:  J Neurooncol       Date:  2010-06-17       Impact factor: 4.130

4.  Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.

Authors:  Lindsay M Morton; Rochelle E Curtis; Martha S Linet; Elizabeth C Bluhm; Margaret A Tucker; Neil Caporaso; Lynn A G Ries; Joseph F Fraumeni
Journal:  J Clin Oncol       Date:  2010-10-12       Impact factor: 44.544

5.  Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases.

Authors:  Meredith S Shiels; Erik H Koritzinsky; Christina A Clarke; Gita Suneja; Lindsay M Morton; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-10       Impact factor: 4.254

6.  The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009.

Authors:  Meredith S Shiels; Eric A Engels; Martha S Linet; Christina A Clarke; Jianmin Li; H Irene Hall; Patricia Hartge; Lindsay M Morton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-17       Impact factor: 4.254

7.  Quality of life, characteristics and survival of patients with HIV and lymphoma.

Authors:  Catherine Diamond; Thomas H Taylor; Hoda Anton-Culver
Journal:  Qual Life Res       Date:  2010-03       Impact factor: 4.147

8.  Trends in primary central nervous system lymphoma incidence and survival in the U.S.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Caroline Besson; Christina A Clarke; Lindsay M Morton; Leticia Nogueira; Karen Pawlish; Elizabeth L Yanik; Gita Suneja; Eric A Engels
Journal:  Br J Haematol       Date:  2016-03-28       Impact factor: 8.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.